SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - FRA:SHL - DE000SHL1006 - Common Stock
48.44 EUR
+0.07 (+0.14%)
We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 59 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
SHL had a positive operating cash flow in the past year.
Each year in the past 5 years SHL has been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of SHL (4.87%) is better than 62.71% of its industry peers.
SHL's Return On Equity of 12.29% is fine compared to the rest of the industry. SHL outperforms 74.58% of its industry peers.
SHL has a better Return On Invested Capital (7.89%) than 69.49% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.04%.
The last Return On Invested Capital (7.89%) for SHL is above the 3 year average (5.87%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
Looking at the Profit Margin, with a value of 9.29%, SHL is in the better half of the industry, outperforming 66.10% of the companies in the same industry.
SHL's Profit Margin has declined in the last couple of years.
SHL has a better Operating Margin (13.76%) than 62.71% of its industry peers.
SHL's Operating Margin has declined in the last couple of years.
SHL has a worse Gross Margin (38.76%) than 76.27% of its industry peers.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
Compared to 1 year ago, SHL has more shares outstanding
SHL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
SHL has an Altman-Z score of 2.10. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
SHL's Altman-Z score of 2.10 is in line compared to the rest of the industry. SHL outperforms 44.07% of its industry peers.
SHL has a debt to FCF ratio of 5.10. This is a neutral value as SHL would need 5.10 years to pay back of all of its debts.
The Debt to FCF ratio of SHL (5.10) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.66 indicates that SHL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.66, SHL is not doing good in the industry: 71.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.1 |
ROIC/WACC1.27
WACC6.21%
2.3 Liquidity
A Current Ratio of 1.12 indicates that SHL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, SHL is doing worse than 69.49% of the companies in the same industry.
SHL has a Quick Ratio of 1.12. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a Quick ratio of 0.77. This is in the lower half of the industry: SHL underperforms 71.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.21% over the past year.
SHL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.27% yearly.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 5.85% in the last year.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.71% yearly.
The Revenue is expected to grow by 5.62% on average over the next years.
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
SHL is valuated rather expensively with a Price/Earnings ratio of 20.35.
Based on the Price/Earnings ratio, SHL is valued a bit cheaper than 79.66% of the companies in the same industry.
When comparing the Price/Earnings ratio of SHL to the average of the S&P500 Index (27.69), we can say SHL is valued slightly cheaper.
SHL is valuated rather expensively with a Price/Forward Earnings ratio of 18.53.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than the industry average as 66.10% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, SHL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.35 | ||
| Fwd PE | 18.53 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 84.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.76 | ||
| EV/EBITDA | 14.86 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.1
PEG (5Y)2.8
EPS Next 2Y8.26%
EPS Next 3Y9.53%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.00%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.36, SHL pays a bit more dividend than its industry peers.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
5.2 History
On average, the dividend of SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.08% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.08%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
FRA:SHL (10/21/2025, 2:40:20 PM)
48.44
+0.07 (+0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap54.64B
Analysts83.7
Price Target61.88 (27.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)-0.53%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-8.5%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-1.03%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.35 | ||
| Fwd PE | 18.53 | ||
| P/S | 2.34 | ||
| P/FCF | 17.76 | ||
| P/OCF | 14.21 | ||
| P/B | 3.09 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.86 |
EPS(TTM)2.38
EY4.91%
EPS(NY)2.61
Fwd EY5.4%
FCF(TTM)2.73
FCFY5.63%
OCF(TTM)3.41
OCFY7.04%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.1
PEG (5Y)2.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.1 |
F-Score8
WACC6.21%
ROIC/WACC1.27
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%